SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 194 filers reported holding SEATTLE GENETICS INC in Q2 2014. The put-call ratio across all filers is 1.41 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $16,160,000 | -13.3% | 460,520 | +11.6% | 0.03% | -15.2% |
| Q4 2015 | $18,641,000 | +2991.4% | 412,586 | +2535.8% | 0.03% | +3200.0% |
| Q3 2015 | $603,000 | -46.2% | 15,653 | -32.4% | 0.00% | -50.0% |
| Q2 2015 | $1,120,000 | +114.1% | 23,158 | +56.4% | 0.00% | +100.0% |
| Q1 2015 | $523,000 | -51.8% | 14,807 | -55.9% | 0.00% | -50.0% |
| Q4 2014 | $1,084,000 | +85.0% | 33,560 | +112.9% | 0.00% | +100.0% |
| Q3 2014 | $586,000 | +6.9% | 15,760 | +0.7% | 0.00% | 0.0% |
| Q2 2014 | $548,000 | +181.0% | 15,653 | +206.4% | 0.00% | – |
| Q1 2014 | $195,000 | +6.6% | 5,109 | +12.2% | 0.00% | – |
| Q4 2013 | $183,000 | -79.8% | 4,553 | -77.9% | 0.00% | -100.0% |
| Q3 2013 | $905,000 | +50.1% | 20,628 | +7.6% | 0.00% | +100.0% |
| Q2 2013 | $603,000 | – | 19,179 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 50,060,240 | $5,775,950,000 | 35.57% |
| Lagoda Investment Management, L.P. | 72,969 | $8,419,000 | 9.97% |
| Avidity Partners Management LP | 580,000 | $66,920,000 | 9.25% |
| Arabesque Asset Management Ltd | 14,807 | $1,708,000 | 3.53% |
| Boxer Capital, LLC | 400,000 | $46,152,000 | 3.15% |
| Woodline Partners LP | 364,333 | $42,037,000 | 3.00% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 56,900 | $6,557,000 | 2.99% |
| SECTORAL ASSET MANAGEMENT INC | 107,000 | $12,346,000 | 2.37% |
| Capital International, Inc./CA/ | 1,197,659 | $138,186,000 | 2.33% |
| Bain Capital Public Equity Management II, LLC | 169,641 | $19,573,000 | 2.29% |